Skip to content

A Multicenter Randomized Controlled Trial of Family-Centered Advance Care Planning in Young and Middle-Aged Patients with Advanced Cancer

A Multicenter Randomized Controlled Trial of Family-Centered Advance Care Planning in Young and Middle-Aged Patients with Advanced Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128875
Enrollment
Unknown
Registered
2026-07-27
Start date
2026-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

intervention group:Family-Centered Advance Care Planning (FC-ACP) Intervention
Comparison group:rountine care

Sponsors

Tianjin Medical University Cancer Institute & Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18–59 years, with no restriction on sex; 2. Pathologically confirmed advanced malignancy (TNM stage IV or deemed unsuitable for curative treatment based on clinical assessment); 3. Estimated life expectancy of >=3 months; 4. Karnofsky Performance Status (KPS) score >=50; 5. Normal cognitive function, with the ability to clearly understand the study content and express personal preferences (confirmed by MMSE screening); 6. Having at least one primary family caregiver (spouse, adult child, or other primary relative) who is able to participate in ACP discussions; 7. Family members willing to jointly participate in the intervention process; 8. Voluntary participation with provision of written informed consent; 9. Agreement to random assignment and subsequent follow-up.

Exclusion criteria

Exclusion criteria: 1. Presence of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder) or significant cognitive impairment; 2. Presence of severe organ failure (e.g., New York Heart Association class IV heart failure, end-stage renal disease) that may impede effective communication and participation; 3. Rapid disease progression with an expected survival of <3 months; 4. Inability to comply with study follow-up (e.g., planned short-term treatment outside the study site or relocation); 5. Prior receipt of formal advance care planning (ACP) interventions or participation in similar studies; 6. Refusal of random assignment or withdrawal of informed consent during the study period

Design outcomes

Primary

MeasureTime frame
Patient–Family Decision Conflict;

Secondary

MeasureTime frame
Advance Care Planning (ACP) wishes fulfillment rate;Sense of dignity;Level of psychological distress;Care satisfaction;Quality of life; Quality of Communication;

Countries

China

Contacts

Public ContactQiang Wanmin

Tianjin Medical University Cancer Institute & Hospital

nursing1331@sina.com+86 186 2222 1009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026